BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37488394)

  • 1. Neoadjuvant Chemotherapy in Retroperitoneal Sarcoma: A National Cohort Study.
    Tortorello GN; Li EH; Sharon CE; Ma KL; Maki RG; Miura JT; Fraker DL; DeMatteo RP; Karakousis GC
    Ann Surg Oncol; 2023 Oct; 30(11):6886-6893. PubMed ID: 37488394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
    Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
    Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
    Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
    World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in patients undergoing neoadjuvant radiation for trunk and extremity soft tissue sarcoma.
    Tortorello GN; Sharon CE; Ma KL; Perry N; Shabason JE; Maki RG; Miura JT; Karakousis GC
    J Surg Oncol; 2023 Sep; 128(4):628-634. PubMed ID: 37148468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern multimodality management of patients with caval leiomyosarcoma: New treatment paradigms and potential molecular insights.
    Squires MH; Politano S; Pollock RE; Chen JL; Grignol V
    J Surg Oncol; 2021 Jun; 123(7):1618-1623. PubMed ID: 33650695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.
    Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M
    Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
    Perez EA; Gutierrez JC; Moffat FL; Franceschi D; Livingstone AS; Spector SA; Levi JU; Sleeman D; Koniaris LG
    Ann Surg Oncol; 2007 Mar; 14(3):1114-22. PubMed ID: 17206483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
    Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
    Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after surgical resection of multiple recurrent retroperitoneal soft tissue sarcoma.
    Willis F; Musa J; Schimmack S; Hinz U; Mechtersheimer G; Uhl M; Schmidt T; Fröhling S; Büchler MW; Schneider M
    Eur J Surg Oncol; 2021 Aug; 47(8):2189-2200. PubMed ID: 33980415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
    Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
    Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.
    Tropea S; Mocellin S; Damiani GB; Stramare R; Aliberti C; Del Fiore P; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2021 May; 47(5):1201-1206. PubMed ID: 32950313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
    Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.
    Stahl JM; Corso CD; Park HS; An Y; Rutter CE; Han D; Roberts KB
    Eur J Surg Oncol; 2017 Jan; 43(1):168-174. PubMed ID: 27335080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.
    Tseng WW; Barretta F; Conti L; Grignani G; Tolomeo F; Albertsmeier M; Angele MK; Rutkowski P; Skoczylas J; De Paoli A; Navarria F; Raut CP; Fairweather M; Farma JM; Nessim C; Goel N; Grignol VP; Ford SJ; Cardona K; Subhawong T; Tattersall HL; Lee RM; Hu JS; von Mehren M; Sanfilippo R; Gronchi A
    Cancer; 2021 Mar; 127(5):729-738. PubMed ID: 33206381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma.
    Almond LM; Tirotta F; Tattersall H; Hodson J; Cascella T; Barisella M; Marchianò A; Greco G; Desai A; Ford SJ; Gronchi A; Fiore M; Morosi C
    Br J Surg; 2019 Mar; 106(4):395-403. PubMed ID: 30675910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients receiving surgery and radiation therapy for retroperitoneal sarcoma: A machine-learning analysis.
    Zeh RD; Konieczkowski D; Shen C; Tsilimigras DI; Kim A; Grignol VP; Contreras CM; Welliver M; Tsung A; Pawlik TM; Pollock RE; Beane JD
    Surgery; 2023 Mar; 173(3):640-644. PubMed ID: 36369098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial.
    Smith MJ; Ridgway PF; Catton CN; Cannell AJ; O'Sullivan B; Mikula LA; Jones JJ; Swallow CJ
    Radiother Oncol; 2014 Jan; 110(1):165-71. PubMed ID: 24411227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant radiotherapy followed by surgery compared with surgery alone in the treatment of retroperitoneal sarcoma: a population-based comparison.
    Turner BT; Hampton L; Schiller D; Mack LA; Robertson-More C; Li H; Quan ML; Bouchard-Fortier A
    Curr Oncol; 2019 Dec; 26(6):e766-e772. PubMed ID: 31896947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.